Where Will CRISPR Therapeutics Be in 10 Years?
The biotech is part of a revolution in gene-editing therapies.
Stay updated with breaking news from Translational Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The biotech is part of a revolution in gene-editing therapies.
The ARC Program strives to increase the number of treatments by promoting innovative scientific design, providing a deeper understanding of regulatory policies, and engaging with patients and their advocates, and other rare disease stakeholders.
Only 1 in 4 residential addiction treatment facilities caring for U.S. adolescents under 18 years old offer buprenorphine, a medication used to treat opioid use disorder, according to a new study.
Uninsured patients with ST-segment elevation myocardial infarction who presented to the ED were less likely to be transferred to another facility than their insured counterparts, a cohort study suggests.
A statewide pay-for-performance intervention based on a set of guidelines called Choosing Wisely reduced rates of inappropriate antibiotic prescriptions to treat acute respiratory tract infections by an average of 18 percentage points, from 43% to 25%, across two large Los Angeles safety net hospitals.